Drugs / BG-A3004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07412691 | Mar 2026 → Aug 2028 expected | skin disorder | BeOne Medicines | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BG-A3004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07412691 ↗ |
| Route | Subcutaneous | “Administered subcutaneously” NCT07412691 ↗ |